原发性慢性免疫性血小板减少症患者发生动脉血栓形成和静脉血栓栓塞事件的风险：一项基于斯堪的纳维亚人群的队列研究。 - Suppr

Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study.

作者信息

Nørgaard Mette, Cetin Karynsa, Maegbaek Merete Lund, Kristensen Nickolaj Risbo, Ghanima Waleed, Bahmanyar Shahram, Stryker Scott, Christiansen Christian Fynbo

机构信息

Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus N, Denmark.

Center for Observational Research, Amgen Inc, Cambridge, MA, USA.

出版信息

Br J Haematol. 2016 Aug;174(4):639-42. doi: 10.1111/bjh.13787. Epub 2015 Oct 12.

DOI:10.1111/bjh.13787

PMID:26456477

Abstract

摘要

相似文献

Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study.

Br J Haematol. 2016 Aug;174(4):639-42. doi: 10.1111/bjh.13787. Epub 2015 Oct 12.

Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia.

J Thromb Haemost. 2019 Jun;17(6):912-924. doi: 10.1111/jth.14446. Epub 2019 Apr 19.

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.

J Thromb Haemost. 2014 Aug;12(8):1266-73. doi: 10.1111/jth.12636. Epub 2014 Jul 16.

Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.

Thromb Res. 2019 Jun;178:124-131. doi: 10.1016/j.thromres.2019.04.016. Epub 2019 Apr 17.

Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.

Br J Haematol. 2011 Feb;152(3):360-2. doi: 10.1111/j.1365-2141.2010.08418.x. Epub 2010 Oct 19.

[Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].

Rev Med Interne. 2011 Dec;32(12):724-9. doi: 10.1016/j.revmed.2011.07.014. Epub 2011 Aug 23.

Thrombosis in patients with primary chronic immune thrombocytopenia.

Thromb Res. 2012 Oct;130 Suppl 1:S74-5. doi: 10.1016/j.thromres.2012.08.282.

Evaluation of thrombotic events in patients with immune thrombocytopenia.

Ann Hematol. 2020 Jan;99(1):49-55. doi: 10.1007/s00277-019-03886-6. Epub 2019 Dec 18.

Is ITP a thrombophilic disorder?

Am J Hematol. 2016 Jan;91(1):39-45. doi: 10.1002/ajh.24234. Epub 2015 Nov 26.

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.

BMJ. 2021 May 5;373:n1114. doi: 10.1136/bmj.n1114.

引用本文的文献

Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature.

Front Cardiovasc Med. 2025 Feb 12;12:1508574. doi: 10.3389/fcvm.2025.1508574. eCollection 2025.

Platelets mediate the clearance of senescent red blood cells by forming prophagocytic platelet-cell complexes.

Blood. 2024 Feb 8;143(6):535-547. doi: 10.1182/blood.2023021611.

Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag.

Hematol Rep. 2023 Sep 12;15(3):518-523. doi: 10.3390/hematolrep15030054.

Mitral valve replacement in patients of rheumatic heart disease associated with immune thrombocytopenia.

Indian J Thorac Cardiovasc Surg. 2023 Sep;39(5):516-521. doi: 10.1007/s12055-023-01517-4. Epub 2023 Jun 1.

Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis.

Thromb J. 2023 Jun 23;21(1):69. doi: 10.1186/s12959-023-00509-z.

[Chinese expert consensus on the diagnosis and treatment of thromboembolism in patients with immune thrombocytopenia (2023)].

Zhonghua Xue Ye Xue Za Zhi. 2023 Jan 14;44(1):6-11. doi: 10.3760/cma.j.issn.0253-2727.2023.01.002.

Assessment and Management of Immune Thrombocytopenia (ITP) in the Emergency Department: Current Perspectives.

Open Access Emerg Med. 2022 Jan 29;14:25-34. doi: 10.2147/OAEM.S331675. eCollection 2022.

Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management.

J Clin Med. 2021 Feb 16;10(4):789. doi: 10.3390/jcm10040789.

Ischemic stroke/transient ischemic attack in adults with primary immune thrombocytopenia: a meta-analysis.

Neurol Sci. 2021 May;42(5):2013-2020. doi: 10.1007/s10072-020-04746-2. Epub 2020 Oct 2.

Thrombopoietin receptor agonists: ten years later.

Haematologica. 2019 Jun;104(6):1112-1123. doi: 10.3324/haematol.2018.212845. Epub 2019 May 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献